Search Results - "Berndtsson, M."

Refine Results
  1. 1

    Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti‐FXa assays by Hillarp, A., Gustafsson, K. M., Faxälv, L., Strandberg, K., Baghaei, F., Fagerberg Blixter, I., Berndtsson, M., Lindahl, T. L.

    Published in Journal of thrombosis and haemostasis (01-09-2014)
    “…Summary Introduction Apixaban is an oral direct factor Xa inhibitor developed for the prophylaxis and treatment of thromboembolic disorders. Laboratory…”
    Get full text
    Journal Article
  2. 2

    Cisplatin and Oxaliplatin Toxicity: Importance of Cochlear Kinetics as a Determinant for Ototoxicity by Hellberg, Victoria, Wallin, Inger, Eriksson, Sofi, Hernlund, Emma, Jerremalm, Elin, Berndtsson, Maria, Eksborg, Staffan, Arnér, Elias S. J., Shoshan, Maria, Ehrsson, Hans, Laurell, Göran

    “…Background Cisplatin is a cornerstone anticancer drug with pronounced ototoxicity, whereas oxaliplatin, a platinum derivative with a different clinical…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Analyzing course configurations for teaching object-oriented modeling and design by Berndtsson, M.

    Published in IEEE transactions on education (01-05-2005)
    “…This paper presents and analyzes an object-oriented analysis and design course that has been given in three different configurations for students who are…”
    Get full text
    Journal Article
  6. 6

    Specific demonstration of drug-induced tumour cell apoptosis in human xenografts models using a plasma biomarker by Olofsson, M Hägg, Cummings, J, Fayad, W, Brnjic, S, Herrmann, R, Berndtsson, M, Hodgkinson, C, Dean, E, Odedra, R, Wilkinson, R W, Mundt, K E, Busk, M, Dive, C, Linder, S

    “…Pharmacodynamic (PD) assays should be used before advancing new drugs to clinical trials. Most PD assays measure the response to drugs in tissue, a procedure…”
    Get more information
    Journal Article
  7. 7

    Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting by Antovic, Aleksandra, Norberg, Eva-Marie, Berndtsson, Maria, Rasmuson, Agnes, Malmström, Rickard E, Skeppholm, Mika, Antovic, Jovan

    Published in Thrombosis and haemostasis (2017)
    “…Laboratory diagnosis of lupus anticoagulant (LA) is based on prolongation in at least one coagulation assay (diluted Russell's viper venom time - dRVVT or…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA by Berndtsson, Maria, Hägg, Maria, Panaretakis, Theocharis, Havelka, Aleksandra Mandic, Shoshan, Maria C., Linder, Stig

    Published in International journal of cancer (01-01-2007)
    “…Cisplatin is a broad‐spectrum anticancer drug that is also widely used in experimental studies on DNA damage‐induced apoptosis. Induction of apoptosis within…”
    Get full text
    Journal Article
  10. 10

    Clinical evaluation of laboratory methods to monitor apixaban treatment in patients with atrial fibrillation by Skeppholm, Mika, Al-Aieshy, Fadiea, Berndtsson, Maria, Al-Khalili, Faris, Rönquist-Nii, Yuko, Söderblom, Lisbeth, Östlund, Annika Y, Pohanka, Anton, Antovic, Jovan, Malmström, Rickard E

    Published in Thrombosis research (01-07-2015)
    “…Abstract Introduction The direct factor-Xa inhibitor apixaban is approved e.g. for the prevention of stroke in patients with atrial fibrillation (AF). Although…”
    Get full text
    Journal Article
  11. 11

    Difference in Fibrin Clot Structure in Haemophilia A and Haemophilia B by Luong, Vincent, Soutari, Nida, Berndtsson, Maria, Holmström, Margareta, Antovic, Jovan P., Chaireti, Roza

    Published in BLOOD (02-12-2016)
    “…Introduction: Hemophilia A and Hemophilia B are X-linked bleeding disorders characterized by deficiency of coagulation factor VIII and IX respectively. The…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    Clinical evaluation of laboratory methods to monitor exposure of rivaroxaban at trough and peak in patients with atrial fibrillation by Al-Aieshy, Fadiea, Malmström, Rickard E, Antovic, Jovan, Pohanka, Anton, Rönquist-Nii, Yuko, Berndtsson, Maria, Al-Khalili, Faris, Skeppholm, Mika

    Published in European journal of clinical pharmacology (01-06-2016)
    “…Purpose The one-dose daily regime of rivaroxaban could cause a pronounced variability in concentration and effect of which a deeper knowledge is warranted…”
    Get full text
    Journal Article
  13. 13

    Induction of Lysosomal Membrane Permeabilization by Compounds That Activate p53-Independent Apoptosis by Erdal, Hamdiye, Berndtsson, Maria, Castro, Juan, Brunk, Ulf, Shoshan, Maria C., Linder, Stig, Sachs, Leo

    “…The p53 protein activates cellular death programs through multiple pathways. Because the high frequency of p53 mutations in human tumors is believed to…”
    Get full text
    Journal Article
  14. 14

    Screening for compounds that induce apoptosis of cancer cells grown as multicellular spheroids by Herrmann, Richard, Fayad, Walid, Schwarz, Stephan, Berndtsson, Maria, Linder, Stig

    Published in Journal of biomolecular screening (01-01-2008)
    “…Screening and initial characterization of anticancer drugs are typically performed using monolayer cultures of tumor cells. It is well established that such…”
    Get more information
    Journal Article
  15. 15

    Evaluation of a diagnostic algorithm for Heparin-Induced Thrombocytopenia by Farm, Maria, Bakchoul, Tamam, Frisk, Tony, Althaus, Karina, Odenrick, Alice, Norberg, Eva-Marie, Berndtsson, Maria, Antovic, Jovan P

    Published in Thrombosis research (01-04-2017)
    “…Abstract Introduction Heparin-Induced Thrombocytopenia (HIT) is a rare but serious immune-mediated complication of heparin treatment. HIT is characterized by…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Thrombin generation test in children and adolescents with chronic liver disease by Magnusson, Maria, Berndtsson, Maria, Fischler, Björn, Petrini, Pia, Schulman, Sam, Renne, Thomas, Granath, Anna, Sten-Linder, Margareta, Németh, Antal

    Published in Thrombosis research (01-02-2015)
    “…Abstract Introduction The aim of this study was to evaluate if real-time thrombin generation assay provides additional information to assess the hemostatic…”
    Get full text
    Journal Article
  18. 18

    Does the intensity and quality of treatment and not only the factor viii level influence global hemostasis in patients with hemophilia a? by Berndtsson, Maria, Zetterberg, Eva, Holmström, Margareta, Mahmoud Hourani Soutari, Nida, Mikovic, Danijela, Elezovic, Ivo, Antovic, Jovan P

    Published in Thrombosis research (01-08-2016)
    “…Highligths • The quality of treatment influences the hemostatic capacity in hemophilia A patients • Patients receiving higher intensity treatment had better…”
    Get full text
    Journal Article
  19. 19

    Restriction of cisplatin induction of acute apoptosis to a subpopulation of cells in a three‐dimensional carcinoma culture model by Fayad, Walid, Brnjic, Slavica, Berglind, Daniel, Blixt, Susanna, Shoshan, Maria C., Berndtsson, Maria, Olofsson, Maria Hägg, Linder, Stig

    Published in International journal of cancer (15-11-2009)
    “…Cisplatin is a clinically important chemotherapeutical agent used to treat epithelial malignancies. High concentrations (20–100 μM) of cisplatin have been used…”
    Get full text
    Journal Article
  20. 20

    Mechanisms of action of DNA-damaging anticancer drugs in treatment of carcinomas: is acute apoptosis an "off-target" effect? by Havelka, Aleksandra Mandic, Berndtsson, Maria, Olofsson, Maria Hägg, Shoshan, Maria C, Linder, Stig

    Published in Mini reviews in medicinal chemistry (01-10-2007)
    “…DNA damage induces apoptosis of cells of hematological origin. Apoptosis is also widely believed to be the major antiproliferative mechanism of DNA damaging…”
    Get more information
    Journal Article